Remicade (infliximab) - J&J
Cimzia (certolizumab pegol) - Astellas, UCB
Tremfya (guselkumab) - J&J
andecaliximab (GS-5745) - āshibio
Omvoh (mirikizumab-mrkz) - Eli Lilly
Orencia (abatacept) - BMS
Enbrel (etanercept) - Pfizer, Amgen
http://www.ncbi.nlm.nih.gov/pubmed/40772520
 
Dalton de Assis de Souza; Daniela Gorski; Fernanda Stumpf Tonin; Helena Hiemisch Lobo Borba; Raul Edison Luna Lazo; Roberto Pontarolo
 
Aug 7, 2025
 
Next